Doxorubicin, as well as the other anthracyclines, are substrates of ATP binding cassette (ABC) transporters, such as P-glycoprotein (Pgp) and multidrug resistance related protein 1 (MRP1), which efflux the drugs outside the tumor cell, thus lowering their cytotoxicity [5]. This evidence concerns the gene ABCB1 and neoplasm.